{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T03:33:39Z","timestamp":1784000019731,"version":"3.55.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001665","name":"French National Research Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014630","name":"Gouvernment Fran\u00e7ais Minist\u00e8re du Travail de la Sant\u00e9 et des Solidarit\u00e9s","doi-asserted-by":"publisher","award":["PHRC-21-0074"],"award-info":[{"award-number":["PHRC-21-0074"]}],"id":[{"id":"10.13039\/501100014630","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jclinepi.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Epidemiology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jclinepi.2025.111677","type":"journal-article","created":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T17:57:53Z","timestamp":1737050273000},"page":"111677","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Incomplete reporting of adverse events in duloxetine trials: a meta-research survey of randomized controlled trials vs placebo"],"prefix":"10.1016","volume":"180","author":[{"given":"P.","family":"Rolland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Jutel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Douget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3760-3801","authenticated-orcid":false,"given":"F.","family":"Naudet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0686-4099","authenticated-orcid":false,"given":"J.C.","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jclinepi.2025.111677_bib1","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/PRS.0b013e3181dc54ee","article-title":"How to practice evidence-based medicine","volume":"126","author":"Swanson","year":"2010","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.jclinepi.2025.111677_bib2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nature25753","article-title":"Meta-analysis and the science of research synthesis","volume":"555","author":"Gurevitch","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jclinepi.2025.111677_bib3","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/1468-0009.12210","article-title":"The mass production of redundant, misleading, and conflicted systematic reviews and meta-analyses","volume":"94","author":"Ioannidis","year":"2016","journal-title":"Milbank Q"},{"key":"10.1016\/j.jclinepi.2025.111677_bib4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jclinepi.2023.02.002","article-title":"A meta-epidemiological study found that meta-analyses of the same trials may obtain drastically conflicting results","volume":"156","author":"Sandau","year":"2023","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jclinepi.2025.111677_bib5","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12916-019-1409-3","article-title":"Vibration of effects from diverse inclusion\/exclusion criteria and analytical choices: 9216 different ways to perform an indirect comparison meta-analysis","volume":"17","author":"Palpacuer","year":"2019","journal-title":"BMC Med"},{"key":"10.1016\/j.jclinepi.2025.111677_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/bmjmed-2022-000154","article-title":"Vibration of effect in more than 16 000 pooled analyses of individual participant data from 12 randomised controlled trials comparing canagliflozin and placebo for type 2 diabetes mellitus: multiverse analysis","volume":"1","author":"Gouraud","year":"2022","journal-title":"BMJ Med"},{"key":"10.1016\/j.jclinepi.2025.111677_bib7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/jrsm.1676","article-title":"A framework to characterise the reproducibility of meta-analysis results with its application to direct oral anticoagulants in the acute treatment of venous thromboembolism","volume":"15","author":"Chapelle","year":"2024","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.jclinepi.2025.111677_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137864","article-title":"Does publication bias inflate the apparent efficacy of psychological treatment for major depressive disorder? A systematic review and meta-analysis of us national institutes of health-funded trials","volume":"10","author":"Driessen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jclinepi.2025.111677_bib9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/bmj.316.7124.61","article-title":"Bias in location and selection of studies","volume":"316","author":"Egger","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.jclinepi.2025.111677_bib10","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1002\/sim.6525","article-title":"Publication bias in meta-analyses from the Cochrane database of systematic reviews","volume":"34","author":"Kicinski","year":"2015","journal-title":"Stat Med"},{"key":"10.1016\/j.jclinepi.2025.111677_bib11","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMsa065779","article-title":"Selective publication of antidepressant trials and its influence on apparent efficacy","volume":"358","author":"Turner","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jclinepi.2025.111677_bib12","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12874-017-0347-z","article-title":"Grey literature in systematic reviews: a cross-sectional study of the contribution of non-English reports, unpublished studies and dissertations to the results of meta-analyses in child-relevant reviews","volume":"17","author":"Hartling","year":"2017","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.jclinepi.2025.111677_bib13","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0140-6736(00)02786-0","article-title":"Does the inclusion of grey literature influence estimates of intervention effectiveness reported in meta-analyses?","volume":"356","author":"McAuley","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jclinepi.2025.111677_bib14","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00006199-200307000-00008","article-title":"Grey literature in meta-analyses","volume":"52","author":"Conn","year":"2003","journal-title":"Nurs Res"},{"key":"10.1016\/j.jclinepi.2025.111677_bib15","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jclinepi.2015.08.021","article-title":"Meta-analyses with industry involvement are massively published and report no caveats for antidepressants","volume":"70","author":"Ebrahim","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jclinepi.2025.111677_bib16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000270917","article-title":"A case study of salami slicing: pooled analyses of duloxetine for depression","volume":"79","author":"Spielmans","year":"2009","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.jclinepi.2025.111677_bib17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13643-022-01945-0","article-title":"Tolerability of duloxetine in elderly and in non-elderly adults: a protocol of a systematic review and individual participant data meta-analysis of randomized placebo-controlled trials","volume":"11","author":"Roy","year":"2022","journal-title":"Syst Rev"},{"key":"10.1016\/j.jclinepi.2025.111677_bib18","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jclinepi.2025.111677_bib19","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1503\/cmaj.081086","article-title":"Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses","volume":"181","author":"Ioannidis","year":"2009","journal-title":"CMAJ (Can Med Assoc J)"},{"key":"10.1016\/j.jclinepi.2025.111677_bib20","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","year":"2019"},{"key":"10.1016\/j.jclinepi.2025.111677_bib21","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jclinepi.2025.111677_bib22","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0033-0620(85)80003-7","article-title":"Beta blockade during and after myocardial infarction: an overview of the randomized trials","volume":"27","author":"Yusuf","year":"1985","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.jclinepi.2025.111677_bib23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2307\/3001666","article-title":"The combination of estimates from different experiments","volume":"10","author":"Cochran","year":"1954","journal-title":"Biometrics"},{"key":"10.1016\/j.jclinepi.2025.111677_bib24","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"issue":"3","key":"10.1016\/j.jclinepi.2025.111677_bib25","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1037\/met0000023","article-title":"A comparison of procedures to test for moderators in mixed-effects meta-regression models","volume":"20","author":"Viechtbauer","year":"2015","journal-title":"Psychol Methods"},{"key":"10.1016\/j.jclinepi.2025.111677_bib26","series-title":"Meta-Analysis with R.","author":"Schwarzer","year":"2015"},{"key":"10.1016\/j.jclinepi.2025.111677_bib29","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-031138","article-title":"Selective reporting bias in randomised controlled trials from two network meta-analyses: comparison of clinical trial registrations and their respective publications","volume":"9","author":"Wong","year":"2019","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.jclinepi.2025.111677_bib30","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/sim.4780060505","article-title":"Issues of efficiency in combining proportions of deaths from several clinical trials","volume":"6","author":"Buyse","year":"1987","journal-title":"Stat Med"},{"issue":"1","key":"10.1016\/j.jclinepi.2025.111677_bib31","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/mpr.139","article-title":"The economic burden of depression and the cost-effectiveness of treatment","volume":"12","author":"Wang","year":"2003","journal-title":"Int J Methods Psychiatr Res"},{"key":"10.1016\/j.jclinepi.2025.111677_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003886","article-title":"Selective publication of antidepressant trials and its influence on apparent efficacy: updated comparisons and meta-analyses of newer versus older trials","volume":"19","author":"Turner","year":"2022","journal-title":"PLoS Med"},{"key":"10.1016\/j.jclinepi.2025.111677_bib33","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1186\/s13063-019-3581-3","article-title":"Opportunities for selective reporting of harms in randomized clinical trials: selection criteria for non-systematic adverse events","volume":"20","author":"Mayo-Wilson","year":"2019","journal-title":"Trials"},{"key":"10.1016\/j.jclinepi.2025.111677_bib34","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1001\/archinternmed.2009.313","article-title":"Adverse events in randomized trials: neglected, restricted, distorted, and silenced","volume":"169","author":"Ioannidis","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jclinepi.2025.111677_bib35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1503\/cmaj.141344","article-title":"If nothing happens, is everything all right? Distinguishing genuine reassurance from a false sense of security","volume":"187","author":"Loke","year":"2015","journal-title":"CMAJ (Can Med Assoc J)"},{"key":"10.1016\/j.jclinepi.2025.111677_bib36","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.euroneuro.2016.09.370","article-title":"Bias in the reporting of harms in clinical trials of second-generation antidepressants for depression and anxiety: a meta-analysis","volume":"26","author":"de Vries","year":"2016","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.jclinepi.2025.111677_bib37","doi-asserted-by":"crossref","DOI":"10.1136\/bmjmed-2022-000352","article-title":"Quality of reporting of adverse events in clinical trials of covid-19 drugs: systematic review","volume":"2","author":"Madi","year":"2023","journal-title":"BMJ Med"},{"key":"10.1016\/j.jclinepi.2025.111677_bib38","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1017\/S0033291718002805","article-title":"Hiding negative trials by pooling them: a secondary analysis of pooled-trials publication bias in FDA-registered antidepressant trials","volume":"49","author":"de Vries","year":"2019","journal-title":"Psychol Med"},{"key":"10.1016\/j.jclinepi.2025.111677_bib39","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/17512433.2017.1377070","article-title":"Efficacy of antidepressants: bias in randomized clinical trials and related issues","volume":"11","author":"Wang","year":"2018","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.jclinepi.2025.111677_bib40","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12916-021-01955-0","article-title":"Reporting of harms in oncological clinical study reports submitted to the European Medicines Agency compared to trial registries and publications\u2014a methodological review","volume":"19","author":"Paludan-M\u00fcller","year":"2021","journal-title":"BMC Med"},{"key":"10.1016\/j.jclinepi.2025.111677_bib41","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1056\/NEJMp1605348","article-title":"Neutral platform for sharing trial data","volume":"374","author":"Bierer","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jclinepi.2025.111677_bib42","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.p601","article-title":"The terminology we use about medical drugs can be misleading","volume":"380","author":"G\u00f8tzsche","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.jclinepi.2025.111677_bib43","doi-asserted-by":"crossref","first-page":"g6501","DOI":"10.1136\/bmj.g6501","article-title":"Selective reporting bias of harm outcomes within studies: findings from a cohort of systematic reviews","volume":"349","author":"Saini","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.jclinepi.2025.111677_bib44","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1017\/S0033291723001058","article-title":"Reporting of harms in clinical trials of esketamine in depression: a systematic review","volume":"53","author":"Taillefer de Laportali\u00e8re","year":"2023","journal-title":"Psychol Med"},{"key":"10.1016\/j.jclinepi.2025.111677_bib45","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jclinepi.2021.04.020","article-title":"Time to improve the reporting of harms in randomized controlled trials","volume":"136","author":"Junqueira","year":"2021","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jclinepi.2025.111677_bib46","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-073725","article-title":"CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomised trials","volume":"381","author":"Junqueira","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.jclinepi.2025.111677_bib47","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0140-6736(19)33220-9","article-title":"Compliance with legal requirement to report clinical trial results on ClinicalTrials.gov: a cohort study","volume":"395","author":"DeVito","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jclinepi.2025.111677_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1010879","article-title":"Ten (not so) simple rules for clinical trial data-sharing","volume":"19","author":"Pellen","year":"2023","journal-title":"PLoS Comput Biol"}],"container-title":["Journal of Clinical Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895435625000101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895435625000101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T04:14:15Z","timestamp":1762316055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0895435625000101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":46,"alternative-id":["S0895435625000101"],"URL":"https:\/\/doi.org\/10.1016\/j.jclinepi.2025.111677","relation":{},"ISSN":["0895-4356"],"issn-type":[{"value":"0895-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incomplete reporting of adverse events in duloxetine trials: a meta-research survey of randomized controlled trials vs placebo","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jclinepi.2025.111677","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111677"}}